跳至主要内容
临床试验/NCT01237535
NCT01237535Unknown4 期

Luteal Phase Support With Progesterone vs Estrogen and Progesterone on Pregnancy Rates in Ovarian Stimulation and Intrauterine Insemination Cycles: a Prospective Randomized Study

Rabin Medical Center1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2011年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
400
试验地点
1
主要终点
Clinical Pregnancy

研究概览

简要总结

This is a single center, 3 arms, prospective randomized controlled open study to determine the impact of luteal phase support on pregnancy rates in ovarian stimulation and IUI cycles with recombinant FSH in patients with unexplained infertility and mild male factor.

Patients will be randomized into 3 groups:

  1. Luteal support with progesterone only (they will received vaginal P gel (Crinone 8% vaginal gel; Serono, Israel)
  2. Luteal support with estrogen + progesterone [(Crinone 8% vaginal gel; Serono, Israel) and Estrofem 4mg].
  3. No luteal support

详细描述

Study design:

single center, 3 arms, prospective randomized controlled open study

Objective:

to determine the impact of luteal phase support on pregnancy rates in ovarian stimulation and IUI cycles with recombinant FSH in patients with unexplained infertility and mild male factor.

Methods:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Couples with diagnosis of unexplained infertility
  • In their treatment cycle with ovarian stimulation and IUI using recombinant FSH in our institution.

排除标准

  • female partners with one or more of the following:
  • previous ovarian surgery
  • one ovary
  • polycystic ovaries on ultrasound examination
  • other endocrine abnormalities (i.e., polycystic ovarian syndrome, thyroid disorders,hyperprolactinemia,6.hypogonadotropic hypogonadism)
  • past ovarian hyperstimulation or hyperstimulation during the study period
  • diminished ovarian reserve (basal FSH level >15 IU/mL)
  • age of >40 years
  • sever male factor < 5 million total motile sperm on the day of insemination.

研究组 & 干预措施

Luteal support with progesterone only

Experimental

Luteal support with progesterone only (they will received vaginal P gel (Crinone 8% vaginal gel; Serono, Israel)Luteal support will begin after insemination and will be continued through the 12th week of gestation if the patient conceived.

干预措施: Luteal support with progesterone only (Drug)

Luteal support with estrogen + progesterone

Experimental

Luteal support with estrogen + progesterone [(Crinone 8% vaginal gel; Serono, Israel) and Estrofem 4mg].

干预措施: Luteal support with estrogen + progesterone (Drug)

No luteal support

No Intervention

干预措施: Insemination without luteal support (Procedure)

结局指标

主要结局

Clinical Pregnancy

时间窗: 4 weeks after insemintation

A pregnancy test will be performed 2 weeks after insemination (Serum hCG) an intrauterine pregnancy will be confirmed using a transvaginal ultrasound 2 weeks after a positive pregnancy test

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Luteal Phase Support With Progesterone Versus... | 临床试验